MIT researchers have developed a computer modeling approach that could improve a class of drugs based on antibodies, molecules key to the immune system.
Read more:http://web.mit.edu/newsoffice/2007/antibody-0923.html
Read more:http://web.mit.edu/newsoffice/2007/antibody-0923.html